A33 antibody‐coated superparamagnetic nanoparticles bound to DOX‐loaded exosomes effectively targeted CRC cells, demonstrating enhanced tumor targeting, antiproliferative effects, reduced cardiotoxicity, and prolonged survival in vivo. The gene discussed is GPA33; the disease is colorectal carcinoma.